Mayssan Muftah

Mayssan Muftah practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Mayssan Muftah's NPI, 1457882078, was assigned on March 24, 2017. Mayssan Muftah holds Massachusetts license 1016724.

Mayssan Muftah's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Mayssan Muftah's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Mayssan Muftah to 1 more hospital outpatient department, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mayssan Muftah practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Mayssan Muftah's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Mayssan Muftah is licensed in Massachusetts.

CMS data shows 247 Medicare services from Mayssan Muftah across 10 procedure codes in 2024, for 181 Medicare patients. Medicare paid $19,457 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 181 Medicare patients who saw Mayssan Muftah in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mayssan Muftah's median patient age at 68, with 60% women.

In 2024, Mayssan Muftah wrote 103 Medicare Part D claims for 50 patients. 73% of them were for generic drugs. CMS names the drug for 52 of them, across 3 drugs with 11 or more claims each, at $7,428 in total drug cost. In 2023, CMS named 20 claims across 1 drug.

Mayssan Muftah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Mayssan Muftah, published from 2018 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Eosinophilic Esophagitis, Enteritis and Eosinophilia. Mayssan Muftah has published most often in Am J Gastroenterol. Mayssan Muftah's most frequent co-authors are Walter Wai-Yip Chan, MD, Wai-Kit Lo, MD and Alison H. Goldin, MD.

CMS Open Payments shows 1 general payment to Mayssan Muftah from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Phathom Pharmaceuticals, Inc. paid the most, $20.